Re
Retrophin (Zevra)
San Diego CAFounded 2011120 employees
Private CapbiotechAcquiredRare Disease
Platform: Thiola
Market Cap
N/A
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Liravorutinib | RET-8421 | Preclinical | 2 | USP1 | GISTPBC | ||
| Terafutibatinib | RET-9812 | Phase 2/3 | 2 | TYK2 | PAH |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (3)